195 results
Keyword Fluoxetine Remove keyword
-
List item
Veterinary medicine European public assessment report (EPAR): Reconcile
fluoxetine, Dogs
Date of authorisation: 08/07/2008, Revision: 12, Authorised, Last updated: 22/04/2020fluoxetine … for the public Reconcile fluoxetine This is a summary of the … contains the active substance fluoxetine. How is Reconcile used … -
List item
Referral: Fluoxetin NM
Fluoxetin, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 18/12/1997, EC decision date: 09/06/1998, Last updated: 19/06/1998Fluoxetin NM … Fluoxetin NM … FOLLOWING AN ARTICLE 10 REFERRAL FLUOXETIN NM International Non-Proprietary … -
List item
Referral: Prozac
fluoxetine, Article 30 referrals
Status: European Commission final decision, opinion/position date: 19/09/2002, Last updated: 18/06/2003Fluoxetine is a Selective Serotonin … the benefit/risk ratio of fluoxetine is considered to be favourable … NonProprietary Name (INN): fluoxetine BACKGROUND INFORMATION Fluoxetine is a Selective Serotonin … -
List item
Referral: Prozac
Fluoxetine, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 01/06/2006, EC decision date: 21/08/2006, Last updated: 05/09/2006arbitration review of Prozac (fluoxetine) and associated names 1 … arbitration review of Prozac (fluoxetine) and associated names1, and … Non-Proprietary Name (INN): Fluoxetine BACKGROUND INFORMATION … -
List item
Referral: Serotonin-specific reuptake inhibitors and serotonin-noradrenaline reuptake inhibitors
atomoxetine, citalopram, escitalopram, fluoxetine, fluvoxamine, mianserine, milnacipran, mirtazapine, paroxetine, reboxetine, sertraline, venlafaxine, Article 31 referrals
Status: European Commission final decision, opinion/position date: 21/04/2005, EC decision date: 19/08/2005, Last updated: 03/11/2005duloxetine, escitalopram, fluoxetine, fluvoxamine, mianserine … duloxetine, escitalopram, fluoxetine, fluvoxamine, mianserine … duloxetine 1 , escitalopram, fluoxetine,fluvoxamine, mianserine, milnacipran … -
List item
Human medicine European public assessment report (EPAR): Valdoxan (updated)
Agomelatine, Depressive Disorder, Major
Date of authorisation: 19/02/2009, Revision: 22, Authorised, Last updated: 14/01/2021other antidepressants, either fluoxetine or paroxetine, as an ‘active … placebo. However, no effect of fluoxetine or paroxetine was seen in … other antidepressants, either fluoxetine or paroxetine, as an ‘active … -
List item
Press release: European Medicines Agency adopts a positive opinion for the use of Prozac in the treatment of children and adolescents suffering from depression
CHMP, Last updated: 06/06/2006the indication for Prozac (fluoxetine) and associated names to … SSRI) medicines, including fluoxetine, regarding the increased risk … the indication for Prozac (fluoxetine) and associated names to … -
List item
Human medicine European public assessment report (EPAR): Thymanax (updated)
Agomelatine, Depressive Disorder, Major
Date of authorisation: 19/02/2009,
Date of refusal: 18/11/2006, Revision: 22, Authorised, Last updated: 14/01/2021other antidepressants, either fluoxetine or paroxetine, as an ‘active … placebo. However, no effect of fluoxetine or paroxetine was seen in … other antidepressants, either fluoxetine or paroxetine, as an ‘active … -
List item
News: European Medicines Agency finalises review of antidepressants in childrenand adolescents
CHMP, Last updated: 25/04/2005duloxetine, escitalopram, fluoxetine, fluvoxamine, mianserine … duloxetine, escitalopram, fluoxetine, fluvoxamine, mianserine … duloxetine, escitalopram, fluoxetine, fluvoxamine, mianserine … -
List item
National expert: Angela Pollicino, Italian Medicines Agency (updated)
- Declaration of interests - 79.75 KB | PDF
- Curriculum Vitae - 18.6 KB | PDF
effect of fluvoxamine or fluoxetine on plasma concetrations of carbamazepine … Carbamazepine coadministrations with fluoxetine or fluvoxamine. Ther Drug … kinetic interaction between fluvoxamine or fluoxetine on plasma concentrations … -
List item
National expert: Ines Ronnefahrt, Federal Institute for Drugs and Medical Devices (updated)
- Declaration of interests - 79.76 KB | PDF
- Curriculum Vitae - 18.5 KB | PDF
Serotonin Re-uptake Inhibitor Fluoxetine: Case Study Using the European … -
List item
National expert: Ekaterini Tiligada, National Organization for Medicines (updated)
- Declaration of interests - 80.06 KB | PDF
- Curriculum Vitae - 38.9 KB | PDF
-
List item
National expert: Emilio Perucca, Italian Medicines Agency (updated)
- Declaration of interests - 85.45 KB | PDF
- Curriculum Vitae - 110.85 KB | PDF
-
List item
National expert: Anette Solli Karlsen, Norwegian Medicines Agency (updated)
- Declaration of interests - 79.8 KB | PDF
- Curriculum Vitae - 86.76 KB | PDF
determination of citalopram, fluoxetine, paroxetine and thier metabolites … -
List item
Human medicine European public assessment report (EPAR): Brintellix (updated)
Vortioxetine, Depressive Disorder, Major
Date of authorisation: 18/12/2013, Revision: 16, Authorised, Last updated: 15/01/2021 -
List item
Human medicine European public assessment report (EPAR): Nodetrip (previously Xeristar)
duloxetine, Anxiety Disorders, Depressive Disorder, Major, Diabetic Neuropathies
Date of authorisation: 17/12/2004, Revision: 31, Authorised, Last updated: 07/12/2020 -
List item
Human medicine European public assessment report (EPAR): Yentreve
duloxetine hydrochloride, Urinary Incontinence, Stress
Date of authorisation: 11/08/2004, Revision: 27, Authorised, Last updated: 22/09/2020the paediatric population: fluoxetine, fluvoxamine, sertraline … -
List item
Human medicine European public assessment report (EPAR): Cymbalta
duloxetine, Anxiety Disorders, Diabetic Neuropathies, Depressive Disorder, Major
Date of authorisation: 17/12/2004, Revision: 30, Authorised, Last updated: 25/09/2020 -
List item
Human medicine European public assessment report (EPAR): Wakix (updated)
pitolisant, Narcolepsy
Date of authorisation: 31/03/2016,
, 
, Revision: 9, Authorised, Last updated: 21/01/2021
-
List item
Human medicine European public assessment report (EPAR): Clopidogrel TAD (updated)
clopidogrel (as hydrochloride), Peripheral Vascular Diseases, Stroke, Myocardial Infarction
Date of authorisation: 23/09/2009,
, Revision: 12, Authorised, Last updated: 18/01/2021
-
List item
Human medicine European public assessment report (EPAR): Grepid (updated)
clopidogrel (as besilate), Peripheral Vascular Diseases, Stroke, Myocardial Infarction
Date of authorisation: 27/07/2009,, Revision: 21, Authorised, Last updated: 15/01/2021
-
List item
Human medicine European public assessment report (EPAR): Clopidogrel Krka (updated)
clopidogrel (as hydrochloride), Peripheral Vascular Diseases, Stroke, Myocardial Infarction
Date of authorisation: 23/09/2009,, Revision: 15, Authorised, Last updated: 13/01/2021
-
List item
Human medicine European public assessment report (EPAR): Ritonavir Mylan
ritonavir, HIV Infections
Date of authorisation: 09/11/2017,, Revision: 8, Authorised, Last updated: 08/12/2020
-
List item
Human medicine European public assessment report (EPAR): Clopidogrel Teva (hydrogen sulphate) (updated)
clopidogrel (as hydrogen sulfate), Acute Coronary Syndrome, Peripheral Vascular Diseases, Myocardial Infarction, Stroke
Date of authorisation: 27/07/2009,, Revision: 15, Authorised, Last updated: 04/01/2021
-
List item
Human medicine European public assessment report (EPAR): Rasagiline ratiopharm
rasagiline, Parkinson Disease
Date of authorisation: 12/01/2015, Revision: 7, Authorised, Last updated: 22/10/2020